ArticleBiomarker research2023

Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study.

Abderrahim Oussalah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.